List of PharmAbcine patents

List of PharmAbcine patents

List of Native Instruments patents

List of Semisouth Laboratories, Inc. patents

List of Delavau Llc patents

Founders educated at NEOMA Business School

List of patents in the Security industry

Patents where

Current Assignee

Name

is

PharmAbcine

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11407833 Anti-VISTA antibody and use thereof	Patent 11407833 was granted and assigned to PharmAbcine on August, 2022 by the United States Patent and Trademark Office.	PharmAbcine	PharmAbcine		United States Patent and Trademark Office	11407833	August 9, 2022
	‌ US Patent 9249219 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof	Patent 9249219 was granted and assigned to PharmAbcine on February, 2016 by the United States Patent and Trademark Office.	PharmAbcine	PharmAbcine		United States Patent and Trademark Office	9249219	February 2, 2016
	‌ US Patent 9249220 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof	Patent 9249220 was granted and assigned to PharmAbcine on February, 2016 by the United States Patent and Trademark Office.	PharmAbcine	PharmAbcine		United States Patent and Trademark Office	9249220	February 2, 2016
	‌ US Patent 10155817 Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same	Patent 10155817 was granted and assigned to PharmAbcine on December, 2018 by the United States Patent and Trademark Office.	PharmAbcine	PharmAbcine		United States Patent and Trademark Office	10155817	December 18, 2018
	‌ US Patent 10106622 Human antibody specific to c-Met and preparation method thereof	Patent 10106622 was granted and assigned to PharmAbcine on October, 2018 by the United States Patent and Trademark Office.	PharmAbcine	PharmAbcine		United States Patent and Trademark Office	10106622	October 23, 2018
	‌ US Patent 11407834 Anti-PD-L1 antibody and use thereof	Patent 11407834 was granted and assigned to PharmAbcine on August, 2022 by the United States Patent and Trademark Office.	PharmAbcine	PharmAbcine		United States Patent and Trademark Office	11407834	August 9, 2022
	‌ US Patent 10125194 Dual targeting antibody of novel form, and use thereof	Patent 10125194 was granted and assigned to PharmAbcine on November, 2018 by the United States Patent and Trademark Office.		PharmAbcine		United States Patent and Trademark Office	10125194	November 13, 2018
	‌ US Patent 9963512 Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same	Patent 9963512 was granted and assigned to PharmAbcine on May, 2018 by the United States Patent and Trademark Office.	PharmAbcine	PharmAbcine		United States Patent and Trademark Office	9963512	May 8, 2018
	‌ US Patent 10597457 EGFRvIII antibody and composition comprising same	Patent 10597457 was granted and assigned to PharmAbcine on March, 2020 by the United States Patent and Trademark Office.	PharmAbcine	PharmAbcine		United States Patent and Trademark Office	10597457	March 24, 2020
	‌ US Patent 9150650 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof	Patent 9150650 was granted and assigned to PharmAbcine on October, 2015 by the United States Patent and Trademark Office.		PharmAbcine		United States Patent and Trademark Office	9150650	October 6, 2015

10 results

0 selected

10 results

0 selected